LRRC32 and neoplasm: Subsequently, the Lucas group demonstrated that antibodies against the mouse GARP:TGF-ß1 complex could overcome resistance to anti–PD-1 agents in a colon carcinoma mouse model and induce T-cell–mediated immunity that protected mice from tumor rechallenge (9).